
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>Regulatory Approval</title>
  <link rel="stylesheet" href="styles.css" />
</head>
<body>
  <header><h1>Regulatory Approval</h1></header>
  <nav><a href="index.html">Back to Home</a></nav>
  <main>
    <section>
      <p>Regulatory approval involves submitting data to agencies like the FDA or EMA for review. Key documents include Investigational New Drug (IND) applications and New Drug Applications (NDA). Challenges include documentation, compliance, and review timelines. Technologies include electronic submission systems and regulatory intelligence platforms. Example: The approval of nivolumab for melanoma followed extensive clinical and regulatory review.</p>
    </section>
  </main>
  <footer><p>&copy; 2025 Drug Discovery Knowledge Base</p></footer>
</body>
</html>
